Kuo, Chang-Fu
Grainge, Matthew J.
Zhang, Weiya
Doherty, Michael
Article History
First Online: 7 July 2015
Competing interests
: W.Z. declares that he has received personal fees from Daiichi Sankyo and is a member of guideline development groups for gout and osteoarthritis for the National Institute for Health and Care Excellence (NICE), EULAR and the British Society for Rheumatology (BSR). M.D. declares that he has received fees from <i>ad hoc</i> advisory activities related to gout and osteoarthritis (outside the submitted work) for Astrazeneca, Menarini, Nordic Biosciences, Novartis and Pfizer; he also declares that he is a clinical expert adviser on gout and osteoarthritis for NICE and a member of guideline development groups for gout for EULAR and BSR. The other authors declare no competing interests.